This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Rye Brook, NY, Xylem Inc. is one of the leading providers of water solutions worldwide. The company is involved in the full water-process cycle, including collection, distribution and returning of water to the environment. It has significant presence in the United States, the Asia Pacific, Europe and various other nations. The company reports business operations under three segmental heads — Water Infrastructure, Sensus and Applied Water.
Here's Why it is Worth Holding on to Xylem (XYL) Stock for Now
by Zacks Equity Research
Xylem (XYL) is likely to gain from solid growth prospects in utilities and commercial end markets, shareholder-friendly policies, and long-term tailwinds. Weakness in the European business is dragging.
Top Analyst Reports for U.S. Bancorp, Duke Energy & Glaxo
by Mark Vickery
Today's Research Daily features updated research reports on 16 major stocks, including U.S. Bancorp (USB), Duke Energy (DUK) and Glaxo (GSK).
Xylem (XYL) Posts In-Line Earnings & Sales in Q2, Lowers View
by Zacks Equity Research
Xylem's (XYL) second-quarter 2019 earnings meet estimates and improve year over year on sales growth and margin improvement. The company lowers 2019 earnings projection.
Xylem (XYL) Q2 Earnings Meet Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 0.00% and 0.02%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Can High Costs & Forex Woes Hurt Xylem (XYL) in Q2 Earnings?
by Zacks Equity Research
Xylem's (XYL) second-quarter 2019 profitability will likely suffer from adverse impacts of forex woes, and high costs related to realignment initiatives, tariffs and growth investments.
Xylem (XYL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) Down 6.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Xylem (XYL) Gains From Solid End Markets Despite Forex Woes
by Zacks Equity Research
Xylem's (XYL) strengthening end markets, shareholder-friendly policies and healthy segmental prospects are boons. High debts and forex woes remain concerns.
Xylem (XYL) Lags Q1 Earnings & Sales Estimates, Lowers View
by Zacks Equity Research
Xylem (XYL) first-quarter 2019 earnings lag estimates and improve year over year on sales growth. It lowers 2019 earnings projection on account of first-quarter results and forex woes.
Xylem (XYL) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of -10.34% and -0.99%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
In first-quarter 2019, Xylem (XYL) is likely to gain from strengthening end markets, solid product portfolio, solid pricing and productivity initiatives. High costs and forex woes remain concerns.
Xylem (XYL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) Q4 Earnings Meet Estimates, Rise on Solid Sales
by Zacks Equity Research
Xylem (XYL) fourth-quarter 2018 earnings meet estimates and improve year over year on sales growth and margin expansion. The company also hikes the dividend rate.
Xylem (XYL) Meets Q4 Earnings Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 0.00% and 1.72%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Xylem's (XYL) fourth-quarter 2018 earnings face risks arising from unfavorable foreign currency movements, tariffs and inflationary pressures. Emerging market growth and pricing actions might work in favor.
Xylem (XYL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Avoid Betting on Xylem (XYL) Stock Now
by Zacks Equity Research
Xylem (XYL) might suffer from rising cost of sales (due to implementation of tariffs), high operating expenses, unfavorable movements in foreign currencies and high debts.
Xylem to Drive Water-Industry Innovation on Imagine H2O Deal
by Zacks Equity Research
Xylem (XYL) will partner with Imagine H2O for supporting the start-up companies of the latter's flagship accelerator program.
Why Is Xylem (XYL) Up 8.5% Since Last Earnings Report?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Xylem (XYL) Signs MoU to Improve Water Security in Ethiopia
by Zacks Equity Research
Xylem (XYL) inks Memorandum of Understanding with the Water, Irrigation and Energy Ministry of Ethiopia, for providing specialized water-technology solutions in the country.
Xylem's (XYL) Q3 Earnings Meet, Revenues Miss Estimates
by Zacks Equity Research
Xylem's (XYL) reports year-over-year higher earnings and revenues in third-quarter 2018.
Xylem (XYL) Q3 Earnings Match Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 0.00% and -0.72%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Xylem's (XYL) third-quarter 2018 financials are expected to gain from its pricing actions and stronger productivity.
Xylem (XYL) Q3 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Must Hold on to Xylem (XYL) Stock for Now
by Zacks Equity Research
Xylem (XYL) gains from a diversified business structure, solid growth opportunities in three segments and shareholder-friendly policies. High debt and rising costs remain concerns.